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Parasitic	   infections	   are	   one	   of	   the	  most	   common	   human	   infections	   around	  
the	   world,	   especially	   in	   refugees.	   The	   current	   standard	   of	   diagnosis	   for	   parasitic	  
infections	   is	   microscopy	   of	   stool	   specimens.	   However	   microscopy	   has	   several	  
limitations,	  some	  of	  which	  include	  time,	  inexperience	  and	  subjectivity	  in	  diagnosis.	  
To	   improve	   the	   specificity,	   sensitivity	   and	   turn-­‐around	   time	   of	   the	   diagnosis	  
method,	  multiplex	   real-­‐time	  PCR	   (RT-­‐PCR)	   diagnosis	   has	   recently	   been	   applied	   in	  
this	  field.	  Multiplex	  RT-­‐PCR	  can	  simultaneously	  amplify	  and	  detect	  the	  presence	  of	  
multiple	  parasites	  in	  one	  sample	  in	  one	  run.	  	  
	  
Methods	  
The	   study	   population	   was	   comprised	   of	   32	   refugees	   arriving	   in	   Texas	  
between	   the	   years	   of	   2010	   and	   2012	   that	   were	   infected	   with	   Giardia	   lamblia,	  
Dientamoeba	   fragilis,	   and/or	   Strongyloides	   stercoralis.	   The	   probe/primer	  mixes	   to	  
identify	   these	   parasites	   using	   multiplex	   RT-­‐PCR	   were	   first	   validated	   in	   uniplex	  
assays	  and	  then	  tested	  for	  effectiveness	  in	  multiplex	  assays.	  	  
	  
Results	  
The	   results	   for	   the	   uniplex	   assay	   suggest	   that	   the	   G.	   lamblia	   (100%	  
agreement	   between	   uniplex	   and	   microscopy)	   and	   D.	   fragilis	   (82.4%	   agreement)	  
probe/primer	   mixes	   were	   validated,	   but	   the	   S.	   stercoralis	   (0%	   agreement)	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probe/primer	  mix	   was	   not.	   A	   specific	   type	   of	   multiplex,	   known	   as	   a	   duplex,	   was	  
conducted	  to	  identify	  the	  parasites	  G.	  lamblia	  and	  D.	  fragilis.	  In	  the	  multiplex	  assay,	  
G.	  lamblia	  had	  a	  100%	  agreement	  while	  D.	  fragilis	  had	  an	  85.7%	  agreement.	  In	  the	  
case	   of	   co-­‐infections,	   there	   was	   a	   100%	   agreement	   to	   identify	   the	   presence	   G.	  
lamblia	  and	  a	  66.7%	  agreement	  to	  identify	  D.	  fragilis.	  There	  was	  a	  0%	  false	  positive	  
rate	  for	  both	  uniplex	  and	  multiplex	  assays	  for	  all	  parasites.	  	  
	  
Conclusion	  
It	   was	   concluded	   that	   the	   multiplex	   RT-­‐PCR	   assay	   to	   diagnose	   these	   two	  













Public	  Health	  Significance	  of	  Parasitic	  Diseases	  	  
Parasites	   infect	   approximately	   one	   billion	   people,	   making	   them	   one	   of	   the	  
most	  common	  human	  infections	  (15,	  25).	  The	  burden	  of	  parasites	  is	  greatest	  in	  the	  
tropic	   and	   sub-­‐tropic	   areas	   of	   the	   world,	   though	   they	   are	   not	   limited	   to	   these	  
geographic	   locations.	   Neglected	   Tropical	   Diseases	   (NTDs)	   are	   diseases	   that	   are	  
endemic	   among	   low-­‐income	   and	   impoverished	   populations.	   Ten	   of	   the	   top	   13	   of	  
NTDs	  are	   caused	  by	  parasites	   (24,	   26).	   	   The	   top	   three	  of	   these	  have	   a	   cumulative	  
prevalence	  of	  two	  billion	  and	  an	  at-­‐risk	  population	  of	  10.6	  billion	  (24).	  Despite	  the	  
fact	   that	   the	  parasitic	  NTDs	  affect	   the	  poor	   in	  disproportionally	  high	  numbers	  and	  
account	  for	  a	  burden	  that	  is	  at	  least	  equivalent	  to	  tuberculosis	  and	  malaria,	  less	  than	  
1%	  of	  overseas	  development	  aid	  is	  used	  to	  control	  these	  diseases	  (18,	  24,	  35).	  	  
Domestically,	  about	  65	  million	  people	  in	  the	  United	  States	  (US)	  are	  infected	  
with	   intestinal	   parasites,	   and	   a	   vast	   majority	   of	   them	   are	   refugees	   (cdc.gov).	   A	  
refugee	  is	  defined	  as	  a	  person	  who	  is	  unable	  or	  unwilling	  to	  return	  to	  his/her	  home	  
country	  due	  to	  fear	  of	  persecution	  based	  on	  race,	  gender,	  belief,	  nationality,	  and/or	  
political	  view	  (cdc.gov).	  All	  refugees	  are	  required	  to	  undergo	  a	  medical	  examination	  
before	  departure	  from	  their	  home	  country	  and	  upon	  arrival	  in	  the	  US	  (44).	  Refugees	  
can	   be	   denied	   entry	   based	   on	   health	   reasons,	   such	   as	   carrying	   a	   disease	   of	  
significant	  public	  health	  importance	  or	  a	  mental	  condition	  associated	  with	  harmful	  
behavior	  (44).	  	  
Prevalence	   rates	   for	   parasitic	   infections	   in	   refugees	   entering	   the	   US	   range	  
from	  a	  low	  of	  8%	  to	  a	  high	  of	  86%	  (cdc.gov).	  There	  are	  multiple	  reasons	  for	  the	  wide	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range	   of	   prevalence	   including	   socioeconomic	   status,	   geography,	   dietary	   habits,	  
living	  conditions,	  and	  standards	  of	  the	  country	  from	  which	  the	  refugees	  are	  arriving	  
(51).	   In	   addition,	   different	   methods	   of	   detection	   have	   been	   shown	   to	   result	   in	  
different	  detection	  rates.	  An	  example	  was	   the	  detection	  of	  parasites	   in	  Cambodian	  
refugee	  populations	   in	  New	  York,	  where	   the	  prevalence	  ranged	   from	  31%	  to	  86%	  
due	  to	  methodological	  differences	  among	  parasitic	  diagnostic	  tests	  (cdc.gov).	  	  
As	   introduced	  previously,	  before	   refugees	   leave	   their	  home	  country	   for	   the	  
US,	   they	   are	   required	   to	   undergo	   a	   pre-­‐departure	   examination	   that	   includes	   a	  
physical,	   diagnostic	   test	   (tuberculosis,	   syphilis,	   etc.),	   and	   vaccination	   check	   by	   an	  
overseas	  panel	   physician,	   an	   appointed	  doctor	   by	   the	  US	   (cdc.gov)	   (5,	   45,	   53).	   To	  
reduce	   the	   parasitic	   prevalence	   rate	   in	   refugees,	   the	   CDC	   recommends	   a	   600	  mg	  
presumptive	   Albendazole	   treatment	   before	   departure	   to	   the	   US,	   and	   the	   World	  
Health	  Organization	   includes	   four	  anthelminthic	  drugs	  on	   their	  essential	  medicine	  
list	  (30,	  48).	  	  
After	   refugees	   arrive	   in	   the	  US,	   a	   domestic	   refugee	  medical	   examination	   is	  
conducted	  (8).	  In	  studies	  by	  Chang	  (2013)	  and	  Shah	  (2008),	  refugees	  in	  2010,	  when	  
compared	  to	  refugees	  in	  2008,	  were	  less	  likely	  to	  be	  infested	  with	  helminths	  partly	  
due	   to	   the	   CDC	   recommended	   presumptive	   Albendazole	   treatment	   (12,	   43).	  
However,	  the	  effectiveness	  of	  this	  treatment	  varies	  from	  high	  to	  minimal	  depending	  
on	  the	  parasitic	  species	  (48).	  
Since	  1975,	  more	  than	  3	  million	  refugees	  have	  entered	  the	  US	  (33).	  Refugees	  
can	  introduce	  new	  or	  existing	  diseases	  to	  areas	  in	  the	  US	  where	  prevalence	  rates	  are	  
low	   (6,	   14,	   41).	   Refugees	   are	   typically	   referred	   to	   Preferred	   Communities	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throughout	  the	  US	  that	  have	  opportunities	  for	  employment,	  independence	  and	  have	  
support	  for	  special	  needs	  populations	  (cdc.gov).	  Upon	  arrival	  in	  such	  communities,	  
refugees	   undergo	   different	   examinations	   dependent	   upon	   the	   state	   to	  which	   they	  
are	  relocated.	  Typically,	   local	  health	  departments	  and	  private	  physicians	  carry	  out	  
these	  examinations.	  
From	  2000	  to	  2011,	  over	  600,000	  refugees	  arrived	  in	  the	  US	  from	  more	  than	  
60	  different	  countries.	  Most	  refugees	  arrived	  from	  Cuba	  or	  the	  former	  Soviet	  Union	  
and	  were	  relocated	  to	  either	  Florida,	  California	  or	  Texas	  (14).	  
	  
Texas	  Refugee	  Demographic	  
According	   to	   the	   Texas	   Department	   of	   State	   Health	   Services	   (DSHS)	   2010	  
Refugee	  Health	  Report,	  over	  9,000	  official	   refugees	  enter	  Texas	  annually.	   In	  2010,	  
the	  majority	   of	   refugees	   arrived	   from	   three	   countries:	   Burma	   (28%),	   Iraq	   (22%),	  
and	  Bhutan	  (12%).	  Houston,	  Dallas,	  and	  Fort	  Worth	  are	  the	  major	  settlement	  areas	  
for	  refugees	  and	  these	  three	  cities	  receive	  about	  70%	  of	  all	  refugees	  that	  come	  into	  
Texas.	  Thirty-­‐seven	  percent	  of	   the	   arriving	   refugees	   in	  2010	  were	  between	  18-­‐32	  
years	  of	  age	  and	  the	  male	  to	  female	  ratio	  was	  1.4	  to	  1	  (dshs.state.tx.us).	  	  
	  
Parasites	  
Ninety	   percent	   of	   refugees	   arriving	   in	   Texas	   were	   screened	   for	   intestinal	  
parasites	   in	   2010,	   and	   of	   those,	   41%	   were	   found	   to	   be	   positive	   for	   at	   least	   one	  
parasitic	   infection;	   18%	   were	   prescribed	   presumptive	   treatment.	   Only	   6%	   of	   all	  
arriving	   refugees	   had	   received	   documented	   overseas	   treatment	   for	   parasites.	   Of	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those	   with	   parasitic	   infections,	   Giardia	   lamblia,	   Entamoeba	   histolytica,	   and	  
Dientamoeba	  fragilis	  accounted	  for	  42%,	  25%	  and	  17%	  of	  all	  infections,	  respectively	  
(dshs.state.tx.us).	  
	  
Profile	  of	  Parasites	  
	   Geographically,	   parasitic	   infections	   typically	   occur	   along	   the	  
equatorial/tropical	  latitudes	  and	  dense	  urban	  populations	  (24).	  Records	  of	  parasitic	  
diseases	   date	   back	   to	   ‘biblical	   times’,	   and	   as	   such	   they	   are	   not	   considered	   as	  
emerging	   diseases	   (24).	   Parasitic	   infections	   tend	   to	   be	   chronic,	   disabling	   diseases	  
that	   cause	   great	   disease	   burden	   (morbidity),	   but	   low	   death	   rates	   (mortality).	   In	  
addition,	   many	   societies	   stigmatize	   people	   with	   parasitic	   infections	   and	   indigent	  
populations	   are	   kept	   impoverished	   due	   to	   the	   combined	   morbidity	   and	   stigma	  
associated	  with	  parasitic	  infections	  (24).	  
The	  focus	  of	  this	  research	  project	  was	  three	  intestinal	  parasites	  G.	  lamblia,	  D.	  
fragilis,	   and	   S.	   stercoralis.	   Recent	   research	   papers	   emphasize	   the	   importance	   of	  
these	   intestinal	   parasites.	   A	   study	   in	   California	   concluded	   that	   G.	   lamblia	   and	   D.	  
fragilis	  were	  the	  two	  most	  common	  protozoan	  infections	  in	  refugees	  (21).	  Another	  
study	  found	  that	  in	  the	  absence	  of	  adequate	  treatment,	  S.	  stercoralis	  can	  persist	  for	  
prolonged	  periods	  of	  time	  (19).	  A	  brief	  physical	  description	  of	  each	  of	  these	  parasite	  




	   G.	   lamblia	   is	   an	   flagellated	   anaerobic	   protozoan	   parasite	   that	   colonizes	   the	  
upper	  part	   of	   the	   small	   intestines	   and	  may	   even	  penetrate	   into	   the	   gallbladder	   of	  
several	  vertebrates	  (29).	  The	  trophozoite	  form	  ranges	  from	  9	  to	  21µm	  in	  length	  and	  
5	  to	  15	  µm	  in	  width,	  while	  the	  cyst	  form	  ranges	  from	  8	  to	  14	  µm	  in	  length	  by	  7	  to	  10	  
µm	  in	  width.	  Both	  forms	  do	  not	  consistently	  appear	  in	  stool	  specimens	  of	  patients;	  
there	  are	  high	  patterns	  (present	  in	  almost	  all	  stools),	  low	  patterns	  (present	  in	  only	  
about	   40%	   of	   stool	   specimens)	   and	   mixed	   patterns	   (alternations	   between	   the	  
previous	  two	  within	  a	  1	  to	  3	  week	  period).	  It	  can	  take	  anywhere	  from	  10	  to	  36	  days	  
for	   G.	   lamblia	   parasites	   to	   be	   detected	   in	   stool	   specimens	   using	   conventional	  
diagnostic	  techniques	  (29,	  32).	  	  
A	   graphical	   depiction	   of	   G.	   lamblia’s	   lifecycle	   is	   shown	   in	   Figure	   1.	   This	  
parasite	   alternates	   between	   a	   trophozoite	   (active,	   feeding	   stage)	   and	   a	   cyst	  
(dormant	  stage).	  G.	  lamblia	  is	  infective	  only	  in	  its	  cyst	  form.	  Infection	  with	  G.	  lamblia	  
usually	  begins	  with	  ingestion	  of	  the	  cysts	  found	  in	  feces	  contaminated	  food	  or	  water,	  
or	  through	  contact	  with	  disease	  vectors	  such	  as	  flies.	  The	  cysts	  are	  able	  to	  survive	  
for	  several	  months	  in	  cold	  water.	  Once	  cysts	  reach	  the	  small	  intestines,	  they	  release	  
two	  trophozoites	  each	  that	  attach	  to	  the	  small	  intestine	  lining	  and	  multiply	  through	  
binary	   fission.	  Upon	  nearing	   the	   colon,	   encystation	   occurs	   and	   cysts	   are	   the	  most	  
common	   form	   found	   in	   non-­‐diarrheal	   feces.	   Diarrheal	   feces	   contain	   fewer	   cysts.	  
Once	   released,	   the	   cysts	   are	   immediately	   infectious.	   It	   is	   unknown	   how	   animal	  
reservoirs	  may	  affect	  transmission	  of	  G.	  lamblia	  in	  humans	  (29,	  32).	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Symptoms	  of	  the	  disease	  giardiasis	   include	  diarrhea,	  malaise,	  excessive	  gas,	  
nausea,	  epigastric	  pain	  and	  upset	  stomach.	  However,	  infections	  are	  often	  completely	  
asymptomatic.	   Children	   are	   more	   vulnerable	   to	   infection	   and	   experience	   more	  
severe	   symptoms.	   Giardiasis	   occurs	  worldwide	   and	   is	   the	  most	   common	  parasitic	  
infection	   in	   the	  US.	   It	   is	   considered	   to	   be	   the	  major	   cause	   of	   diarrheal	   outbreaks,	  
usually	   due	   to	   contaminated	   water	   supplies.	   Children	   under	   5	   years	   of	   age	   and	  
childbearing	  women,	  both	  of	  which	  are	  exposed	  at	  day	   care	   centers,	   are	   the	  most	  
vulnerable	   to	   transmission	   of	   giardiasis.	   However,	   giardiasis	   is	   usually	   not	   a	   life-­‐
threatening	  disease	  even	  in	  those	  who	  are	  immunocompromised	  (29,	  32).	  
First	   line	   treatments	   of	   giardiasis	   include	   metronidazole	   and	   tinidazole.	  
Nirazoxanide	   is	  a	   liquid	   formula	  suitable	   for	  children.	  Additional	   therapies	   include	  
albendazole	   and	   mebendazole.	   G.	   lamblia	   cysts	   are	   resistant	   to	   filtration	   and	  
chlorination,	  but	  double	  strength	  iodine	  solutions	  for	  20	  minutes	  have	  been	  shown	  
to	  be	  effective	  at	  killing	  them	  (29).	  
	   D.	   fragilis	   is	   a	   single-­‐celled	  parasite	   found	   in	   the	   large	   intestine	  of	  humans,	  
dogs,	  and	  gorillas.	  It	  can	  range	  from	  3	  to	  18	  µm	  in	  diameter	  and	  there	  is	  no	  known	  
cyst	  form	  of	  the	  parasite.	  D.	  fragilis	  has	  rarely	  been	  seen	  to	  ingest	  red	  blood	  cells	  and	  
almost	  never	  invades	  tissue.	  A	  unique	  characteristic	  of	  D.	  fragilis	  is	  that	  it	  does	  not	  
survive	   very	   long	   in	   stool	   outside	   the	   host	   body.	   Prevalence	   rates	   for	   D.	   fragilis	  
range	  from	  1.5%	  to	  20%,	  but	  it	  is	  very	  probable	  that	  the	  true	  rate	  in	  most	  areas	  is	  
not	   known,	   because	   significantly	   higher	   prevalence	   rates	   are	   found	   when	   stool	  
specimens	  are	  immediately	  preserved	  in	  polyvinyl	  alcohol	  (29,	  32).	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Figure	  2	  presents	  a	  diagrammatic	  representation	  of	  the	  life	  cycle	  of	  D.	  fragilis.	  
The	  complete	  life	  cycle	  of	  this	  parasite	  is	  not	  completely	  understood;	  it	  is	  assumed	  
to	  be	  transmitted	  by	  way	  of	  intestinal	  nematodes	  (29).	  The	  lack	  of	  an	  infective	  cyst	  
stage	   common	   to	  most	   other	   parasites	   further	   shrouds	   the	  mode	  of	   transmission.	  
Based	  on	  clinical	  data,	  transmission	  is	  believed	  to	  occur	  through	  the	  fecal-­‐oral	  route	  
and	  co-­‐transmission	  with	  helminth	  eggs	  is	  another	  possibility	  (29,	  32).	  	  
Symptoms	  of	  dientamoebiasis	  include	  abdominal	  pain,	  diarrhea,	  weight	  loss	  
and	   fever	   (29).	   There	   is	   a	   higher	   coincidence	   rate	   of	   dientamoebiasis	   with	  
enterobiasis	   that	   cannot	  be	  explained	  by	  chance	  alone.	  Low	   infection	  rates	  among	  
homosexual	   men	   in	   the	   Oakland	   suggest	   that	   the	   disease	   is	   not	   transmitted	   via	  
ordinary	  fecal-­‐oral	  route	  (29,	  32).	  	  
Iodoquinol	  is	  the	  main	  drug	  used	  to	  treat	  dientamoebiasis,	  and	  tetracycline	  is	  
an	   alternative.	   In	   cases	   where	   these	   two	   drugs	   do	   not	   work,	   paromomycin	   is	   a	  
second	  line	  drug	  that	  has	  been	  found	  to	  be	  very	  effective	  (29).	  
	   S.	  stercoralis	  is	  a	  parasitic	  nematode	  that	  is	  generally	  ranges	  from	  1	  to	  2	  mm	  
long	  and	  only	   infects	  humans.	  S.	  stercoralis	  can	  often	   infect	   the	   lung	  as	  well	  as	   the	  
large	   intestine	   depending	   on	   the	   migratory	   route.	   Different	   Strongyloides	   species	  
can	  also	  infect	  cats	  and	  dogs,	  but	  these	  species	  are	  generally	  host	  specific	  although	  
human	   infections	   from	  a	  dog	  have	  been	  documented	   (29).	   Strongyloidiasis	   differs	  
from	   hookworm	   infections	   in	   that	   while	   most	   hookworm	   infections	   die	   out	   over	  
time,	  hosts	  can	  be	  infected	  by	  S.	  stercoralis	  for	  an	  indefinite	  amount	  of	  time	  (29,	  32).	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   A	  graphic	  representation	  of	  S.	  stercoralis’s	  life	  cycle	  is	  shown	  in	  Figure	  3.	  The	  
life	   cycle	   is	   complicated;	  S.	   stercoralis	   alternates	  between	   a	   free-­‐living	   form	  and	   a	  
parasitic	  form.	  The	  free-­‐living	  form	  can	  penetrate	  the	  skin	  of	  any	  potential	  host	  with	  
which	  it	  comes	  into	  contact.	  Once	  inside	  the	  host,	  female	  larvae	  develop	  and	  burrow	  
into	  the	  intestinal	  lining	  where	  they	  lay	  eggs.	  This	  dual	  life	  cycle	  allows	  S.	  stercoralis	  
to	  live	  in	  unfavorable	  conditions	  outside	  a	  host	  for	  many	  years	  until	  contact	  with	  a	  
suitable	  host	  (29,	  32).	  	  
Symptoms	  of	  strongyloidiasis	  include	  lesions	  around	  the	  penetration	  point	  of	  
the	  larvae,	  burning	  pain,	  sepsis,	  weight	  loss	  and	  ulcers.	  In	  immunocompromised	  or	  
severely	  malnourished	   patients,	   strongyloidiasis	   can	   enter	   a	   hyperinfection	   state,	  
which	   includes	   fever,	   dyspnea,	   respiratory	   failure	   and	   hemoptysis	   (39).	   The	  
mortality	   rate	   for	   the	   hyperinfection	   state	   can	   reach	   up	   to	   90%	   (34).	   A	   unique	  
phenomenon	   of	   strongyloidiasis	   is	   auto-­‐infection.	   In	   auto-­‐infection,	   the	   larvae	  
develop	  in	  the	  gut,	  circulate	  back	  up	  to	  the	  lungs	  and	  then	  migrate	  back	  down	  into	  
the	  small	   intestine,	  starting	   the	  whole	  cycle	  over	  again.	  The	  numbers	  of	  migratory	  
larvae	  can	  grow	  so	  large	  that	  they	  will	  cause	  injury	  to	  other	  vital	  organs,	  including	  
the	   liver,	   heart,	   pancreas,	   kidneys	   and/or	   central	   nervous	   system.	   Even	   in	   areas	  
where	  strongyloidiasis	  is	  not	  endemic,	  it	  can	  persist	  for	  years	  in	  a	  host	  (again,	  due	  to	  
auto-­‐infection)	   (37).	   Examples	   of	   such	   infections	   included	   prisoners	   of	   war	   that	  
were	   detained	   in	   WWII,	   who	   contracted	   the	   parasites	   and	   were	   still	   infected	   65	  
years	  later	  (29,	  32).	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Treatment	   options	   for	   strongyloidiasis	   include	   albendazole	   and	   ivermectin.	  
Cases	   of	   hyperinfection	   require	   higher	   doses	   of	   these	   drugs.	   Ivermectin	   has	   also	  
been	  found	  to	  be	  very	  successful	  in	  eliminating	  strongyloidiasis	  (29).	  
	  
Diagnostic	  Techniques	  for	  the	  Identification	  of	  Intestinal	  Parasites	  
	   The	  standard	  method	  of	  laboratory	  diagnosis	  for	  intestinal	  parasites	  is	  light	  
microscopy.	  First,	  a	  stool	  specimen	  is	  collected	  from	  the	  patient	  preferably	  within	  an	  
hour	   after	   defecation.	   It	   is	   recommended	   three	   specimens	   be	   collected	   spaced	   at	  
least	   48	   hours	   apart	   (cdc.gov).	   Stool	   specimen	   consistency	   before	   preservation	   is	  
critical	   to	   the	   parasite	   identification	   process.	   Intestinal	   protozoan	   parasite	  
trophozoites	   (easier	   to	   identify	   than	   cysts)	   are	   found	   in	   liquid	   or	   soft	   stool,	   and	  
almost	   never	   found	   in	   fully	   formed	   stool.	   Protozoan	   cysts,	   on	   the	   other	   hand,	   are	  
generally	   found	   in	   fully	   formed	  stool,	  and	  rarely	   found	   in	   liquid	  or	  soft	   stool	   (29).	  
Adding	  a	  10%	  formalin	  and	  polyvinyl	  alcohol	  preservative	  solution	  in	  a	  1:3	  stool	  to	  
preservative	  ratio	  preserves	  these	  specimens.	   	  This	  solution	  allows	  for	  a	  long	  shelf	  
life	  at	   room	  temperature.	  Helminth	  and	  other	  macroscopic	  parasites	   can	  be	   found	  
on	  the	  surface	  of	  unpreserved	  stool	  specimen	  (29).	  
Three	  common	  techniques	  are	  used	  to	  identify	  parasites	  in	  stool	  specimens.	  
The	  easiest	  way	  to	  detect	  trophic	  forms	  of	  parasites	  is	  a	  direct	  wet	  mount	  (C.	  Snider,	  
personal	   communication).	   This	   involves	   mixing	   a	   small	   portion	   of	   the	   feces	  
(preferably	  feces	  that	  have	  just	  been	  collected	  and	  not	  preserved)	  with	  saline	  on	  a	  
clean	   microscopic	   slide.	   Then,	   the	   slide	   is	   checked	   under	   a	   light	   microscope	   for	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parasites,	  and	  if	  needed,	  it	  is	  stained	  to	  enhance	  contrast	  (especially	  for	  cysts)	  (47).	  
However,	   staining	   will	   kill	   most	   trophozoites,	   thus,	   they	   might	   be	   unidentifiable	  
after	  staining.	  
A	   second	   technique	   used	   to	   detect	   intestinal	   parasites	   is	  
sedimentation/flotation	  separation.	  This	  technique	  takes	  advantage	  of	  the	  differing	  
densities	   between	   eggs/cysts	   and	   the	   suspending	   liquid.	   Thus,	  when	   spun	   at	   high	  
speeds,	   the	   eggs/cysts	   will	   separate	   from	   the	   suspending	   liquid	   (2).	   In	  
sedimentation,	   the	   eggs/cysts	  will	   concentrate	   in	   a	  pellet	   at	   the	  bottom	  of	   a	   tube,	  
while	   in	   flotation,	   the	   eggs/cysts	  will	   rise	   to	   the	   surface	   of	   the	   suspending	   liquid.	  
The	  concentrated	  specimen	  can	  then	  be	  collected	  and	  examined	  for	  the	  presence	  of	  
parasites,	  eggs	  and/or	  cysts.	  The	  addition	  of	  a	  stain	  may	  also	  be	  used	  to	  assist	  with	  
the	   detection	   of	   parasites	   (13,	   29).	   Additionally,	   a	   combination	   of	   these	   three	  
techniques	  may	  be	  used	  to	  ensure	  accuracy.	  
A	   third	   technique,	   permanent	   stained	   slides,	   is	   the	  most	   accurate	   of	   these	  
three	   detection	   techniques.	   This	   technique	   involves	   smearing	   a	   thin	   film	   of	   feces	  
(preferably	   fresh)	   onto	   a	   clean	   slide	   and	   then	   permanently	   staining	   it	   in	   order	   to	  
reveal	  much	  more	  detail	  than	  a	  direct	  wet	  mount	  (17).	  This	  method	  alone	  has	  been	  
proven	   to	   detect	   a	   significantly	   higher	   percentage	   of	   parasites	  when	   compared	   to	  
just	  direct	   examination	  or	   concentration	   techniques	   (29).	  The	  use	  of	   a	  permanent	  




Advantages	  and	  Disadvantages	  of	  Microscopy	  
Microscopic	   techniques	   for	   the	   identification	   of	   parasites	   are	   limited	   in	  
several	   ways.	   In	   a	   study	   on	   Plasmodium	   spp.,	   Barber	   and	   coworkers	   (2013)	  
documented	   that	   it	   was	   difficult	   to	   differentiate	   closely	   related	   species	   via	  
microscopy	   due	   to	   similar	   morphologies	   (3).	   The	   identification	   of	   parasites	  
microscopically	  is	  selective	  and	  depends	  on	  the	  skill	  of	  the	  laboratory	  professional	  
in	  evaluating	   the	  direct	  wet	  mount,	   concentrated	  solution,	  or	  permanently	  stained	  
slides.	  There	  are	  many	  reasons	  for	  this	  variability,	  including	  the	  limited	  period	  that	  
parasites	  are	  shed,	  the	  differing	  levels	  of	  experience	  of	  the	  microscopists,	  improper	  
handling	   of	   the	   specimen,	   etc..	   In	   addition,	   it	   is	   much	   more	   difficult	   to	   diagnose	  
intestinal	  parasites	  in	  fecal	  specimens	  when	  only	  one	  specimen	  is	  evaluated	  (29).	  
The	   sensitivity	   of	   a	   diagnostic	   test	   is	   the	   proportion	   of	   tested	   positives	   in	  
relation	   to	   true	   positives.	   Reported	   sensitivity	   for	   the	   detection	   of	   parasites	   by	  
microscopy	   varies	   widely	   in	   literature,	   ranging	   from	   <10%	   to	   85%	   according	   to	  
different	  sources	  (11,	  46).	  In	  addition,	  detection	  rates	  are	  highly	  variable	  depending	  
on	   the	   parasitic	   species	   and	   there	   are	   difficulties	   distinguishing	   between	   closely	  
related	   parasites.	   Microscopic	   specificity,	   the	   proportion	   of	   tested	   negatives	   in	  
relation	  to	  true	  negatives,	  suffers	  a	  similar	  fate	  with	  reported	  ranges	  of	  10%	  to	  50%,	  
varying	  widely	  based	  on	  different	  sources	  (11,	  46).	  
An	  alternative	  to	  microscopy	  for	  parasitic	  diagnosis	  is	  serologic	  testing.	  This	  
involves	  testing	  a	  serum	  specimen	  for	  the	  presence	  of	  specific	  antibodies	  produced	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by	  the	  body	  due	  to	  the	  presence	  of	  a	  parasitic	  infection.	  Serologic	  testing	  is	  usually	  
used	  in	  conjunction	  with	  a	  traditional	  stool	  examination	  (29).	  Serologic	  tests	  require	  
that	  the	  patient’s	   immune	  system	  be	  functional	  and	  reacting	  to	  an	  active	   infection,	  
meaning	   it	   is	   less	   effective	   for	   patients	   that	   were	   very	   recently	   infected	   or	   are	  
immunocompromised	  (29).	  Recent	  studies	  have	  revealed	  that	  serological	  testing	  is	  a	  
useful	  tool	  in	  monitoring	  treatment	  of	  infections	  and	  has	  a	  higher	  detection	  rate	  for	  
S.	  stercoralis	  than	  microscopic	  stool	  exams	  (7,	  9,	  12).	  
	   The	   detection	   of	   intestinal	   parasites	   can	   be	   considerably	   improved	   with	  
respect	  to	  specificity	  and	  sensitivity	  by	  the	  use	  of	  molecular-­‐based	  tests	  such	  as	  the	  
polymerase	   chain	   reaction	   (PCR)	   (29).	   PCR	   is	   based	   on	  nucleic	   acid	   hybridization	  
and	  the	  reaction,	  assisted	  by	  primers,	  amplifies	  the	  nucleic	  acid	  sequences.	  Primers	  
target	   very	   specific	   sequences	   and	   different	   sequences	   can	   be	   amplified	   using	  
different	   primers.	   Once	   bound,	   these	   primers	   assist	   with	   initiation	   of	   elongation,	  
which	   produces	   a	   complementary	   DNA	   strand.	   As	   these	   strands	   separate,	   the	  
primers	  re-­‐attach	  to	  the	  complementary	  DNA	  strands,	  and	  the	  process	  repeats	  itself	  
(1).	  
To	  detect	  the	  presence	  of	  a	  specific	  DNA	  strand,	  complementary	  probes	  are	  
used.	   These	   probes	   bind	   to	   complementary	   sequences,	   and	   they	   contain	   a	  
fluorescent	   protein	   that	   will	   fluoresce	   under	   specific	   conditions.	   The	   detection	   of	  
fluorescence	   indicates	   the	   presence	   of	   the	   probe,	   and	   that	   specific	   nucleic	   acid	  
sequences	   are	   present	   in	   the	   sample	   (1).	   	   The	   addition	   of	   fluorescent	   probes	   to	  
target	  a	  specific	  sequence	  while	  simultaneously	  amplifying	   the	  sequence	   is	  known	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as	  real-­‐time	  PCR,	  as	  opposed	  to	  traditional	  PCR	  where	  the	  nucleic	  acid	  sequence	  is	  
just	  amplified	  by	  primers	  (16,	  28,	  36).	  Investigations	  have	  shown	  that	  real-­‐time	  PCR	  
can	  detect	  microorganisms	  with	  high	  specificity	  and	  sensitivity	  (up	  to	  100%)	  (49).	  
Using	  probes	   that	   fluoresce	  at	  different	  wavelengths	   in	   a	   single	   assay,	   a	  multiplex	  
real-­‐time	  PCR,	  makes	  it	  possible	  to	  identify	  multiple	  species	  or	  multiple	  pathogens	  
simultaneously.	   The	   detection	   of	   different	   fluorescent	   wavelengths	   enables	   the	  
identification	  of	  which	  specific	  species	  or	  pathogens	  are	  present	  in	  the	  specimen.	  
	  
The	  Essential	  Steps	  in	  RT-­‐PCR	  
	   The	  first	  step	  in	  RT-­‐PCR	  is	  extraction	  of	  the	  DNA	  from	  the	  stool	  specimens.	  A	  
lysis	   buffer	   is	   used	   to	   expose	   the	   parasite’s	   DNA	   in	   the	   stool	   specimen.	   Then,	  
proteins,	  RNA	  and	  other	  miscellaneous	  non-­‐DNA	  molecules	  are	   removed	   from	   the	  
sample,	   usually	   through	  degradation	  with	   an	   enzyme.	   Inhibition	  of	  DNases	   is	   also	  
done	  to	  prevent	  the	  degradation	  of	  the	  purified	  DNA.	  
The	  second	  step	  in	  RT-­‐PCR	  is	  PCR	  amplification	  and	  detection	  of	  parasites.	  If	  
a	  parasite	  is	  present	  in	  a	  stool	  specimen,	  then	  the	  corresponding	  primer	  will	  assist	  
with	   the	  replication	  of	  a	  nucleic	  acid	  sequence	  unique	   to	   that	  parasite,	  and	   then	  a	  
corresponding	  probe	  will	  attach	  to	  the	  sequence.	  If	  the	  machine	  detects	  the	  specific	  
fluorescence	   wavelength	   of	   that	   probe,	   then	   the	   sample	   will	   be	   positive	   for	   the	  
parasite	  corresponding	  to	  that	  probe.	  Testing	  for	  one	  parasite	  at	  a	  time	  in	  a	  single	  
run	   in	   this	   fashion	   is	   a	   technique	   known	   as	   uniplex	   PCR.	   Testing	   for	   multiple	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parasites	   in	   a	   single	   run	   with	   matching	   primers	   and	   probes	   (of	   different	  
wavelengths)	  is	  a	  technique	  known	  as	  multiplex	  PCR	  (42).	  
	  
Advantages	  and	  Disadvantages	  of	  RT-­‐PCR	  
The	  combination	  of	  real-­‐time	  PCR	  and	  multiplexing	  offers	  many	  advantages,	  
including	   an	   increase	   in	   sensitivity,	   specificity	   and	   turn-­‐around-­‐time	   (4).	  
Theoretically,	   the	   DNA	   from	   even	   a	   single	   parasite	   can	   be	   detected	   due	   the	  
amplification	  of	  DNA.	  Real-­‐time	  multiplex	  PCR	  eliminates	  many	   sources	  of	  human	  
error	  such	  as	   inexperience,	  overburden,	  morphologically	  ruined	  samples,	  etc.	  (38).	  
Disadvantages	   to	   this	  method	   include	  costs,	   an	  overlap	   in	  emission	   spectra	   (if	   the	  
fluorescence	   wavelengths	   are	   too	   close),	   and	   the	   vulnerability	   of	   samples	   due	   to	  
improper	  handling	  (31).	  
Several	   research	   studies	  have	  demonstrated	   that	  a	  multiplex	   real-­‐time	  PCR	  
assay	   can	   be	   used	   with	   confidence	   to	   simultaneously	   identify	   E.	   histolytica,	  
Cryptosporidium	   parvum	   and	   G.	   lamblia.	   When	   compared	   to	   a	   gold	   standard	  
(positive	   in	  both	  an	  antigen	   test	  and	  singleplex	  PCR	   test),	  multiplex	  real-­‐time	  PCR	  
test	  had	  an	  88%	  sensitivity	  and	  98%	  specificity	  across	  all	  three	  parasitic	  species.	  It	  
was	   concluded	   that	   multiplex	   PCR	   assays	   provided	   an	   alternative	   method	   for	  
multiplex	  antigen	  assay	  tests,	  which	  has	  not	  been	  developed	  yet	  (only	  singleplex	  is	  
clinically	  used)	  (22).	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In	  another	  study	  by	  Verweij	  and	  coworkers	  (2004),	  E.	  histolytica,	  G.	  lamblia,	  
and	  C.	  parvum	  were	  identified	  in	  a	  multiplex	  real-­‐time	  PCR	  assay.	  This	  study	  found	  a	  
100%	   specificity	   across	   all	   three	   parasitic	   species	   when	   compared	   to	   the	   gold	  
standard	  of	  microscopic	  testing,	  and	  that	  multiplex	  assays	  were	  just	  as	  effective	  as	  
single	   assays.	   These	   authors	   concluded	   that	  multiplex	   real-­‐time	   PCR	   is	   a	   feasible	  
technique	  for	  the	  routine	  diagnosis	  of	  these	  parasitic	  infections	  (52).	  
Duplex	  real-­‐time	  PCR	  (the	  simultaneous	   testing	  of	   two	  parasitic	   species)	   to	  
identify	   E.	   histolytica,	   Cryptosporidium	   spp.	   and	   D.	   fragilis	   was	   also	   found	   to	   be	  
superior	  to	  microscopy	  in	  terms	  of	  sensitivity.	  Bruijnesteijn	  and	  coworkers	  (2009)	  
conducted	   a	   study	   in	   northwest	   Europe	   and	   they	   concluded	   that	   real-­‐time	   PCR	  
improved	  diagnostic	  yield	  by	  18%	  (10).	  
A	   recent	   study	  by	  Tuniuchi	  and	  coworkers	   (2011)	   found	   that	  by	  using	   two	  
multiplex	  real-­‐time	  PCR	  assays,	  it	  was	  possible	  to	  test	  for	  a	  total	  of	  seven	  parasites.	  
These	  investigators	  found	  between	  an	  83-­‐100%	  sensitivity	  and	  specificity	  across	  all	  
seven	  parasites	  and	  concluded	  that	  the	  use	  of	  molecular	  methods	  is	  a	  highly	  useful	  
as	   laboratories	   are	   quickly	   losing	   expertise	   to	   detect	   parasites	   using	   stool	  
microscopy	  (50).	  
The	   purpose	   of	   this	   research	   was	   to	   determine	   if	   real-­‐time	  multiplex	   PCR	  
could	  be	  configured	  to	  simultaneously	  amplify	  and	  detect	  the	  presence	  of	  G.	  lamblia,	  
D.	  fragilis,	  and	  S.	  stercoralis.	  The	  sensitivity,	  specificity,	  advantages,	   limitations	  and	  
practical	  uses	  of	  this	  technique	  were	  evaluated	  against	  the	  current	  standard	  method	  




MATERIALS	  AND	  METHODS	  
Study	  Specimens	  
	   The	   data	   for	   this	   project	   were	   taken	   from	   the	   Texas	   DSHS	   Parasitology	  
Database.	   Fecal	   samples	   from	   around	   the	   state	   were	   collected	   and	   sent	   to	   the	  
medical	   parasitology	   team	   at	   DSHS.	   They	   receive	   a	   total	   of	   about	   7,500	   fecal	  
specimens	  a	  year	  (C.	  Snider,	  personal	  communication).	  Thirty-­‐two	  samples	  (each	  no	  
more	   than	   two	   years	   old)	   were	   selected	   from	   fecal	   specimens	   reserved	   at	   DSHS	  
from	  2010	  to	  2012.	  Each	  sample	  contained	  at	  least	  one	  of	  three	  parasites:	  G.	  lamblia,	  
D.	  fragilis	  or	  S.	  stercoralis.	  These	  samples	  were	  sent	  to	  the	  molecular	  biology	  team	  to	  
be	  tested	  by	  multiplex	  RT-­‐PCR.	  	  
	  
Protocol	  for	  Multiplex	  Real-­‐Time	  PCR	  
The	  detailed	  protocol	  used	  for	  real-­‐time	  PCR	  analysis	  can	  be	  found	  in	  Appendices	  A,	  
B,	  C,	  and	  D	  .	  Appendix	  A	  details	  the	  method	  of	  extraction,	  storage,	  and	  setup	  for	  
multiplex	  RT-­‐PCR.	  Appendix	  B	  details	  the	  specific	  concentrations	  of	  the	  mastermix	  
used	  in	  multiplex	  RT-­‐PCR.	  Appendix	  C	  contains	  the	  specific	  runtime	  instructions	  for	  




Validation	  of	  Parasite	  Probe/Primer	  
	   The	  probes	  and	  primers	  for	  each	  of	  the	  three	  parasites	  were	  first	  validated	  in	  
an	  uniplex	  assay	  to	  ensure	  that	  they	  worked.	  The	  first	  step	  was	  vertrel	  extraction	  of	  
the	  parasites	  from	  the	  stool	  sample	  by	  the	  addition	  of	  lysis	  buffer,	  and	  followed	  by	  
centrifugation	   of	   the	   sample.	   The	   second	   step	   involved	   the	   extraction	   of	   parasitic	  
DNA	   from	   that	   sample	   using	   the	   MagNA	   Pure	   instrument.	   Lastly	   a	   sample	   plate,	  
which	   contained	   extracted	   parasitic	   DNA	   and	   a	   probe	   for	   a	   single	   parasite,	   was	  
loaded	   into	   the	  LightCycler	  480	  PCR	  machine	   for	  analysis.	  Each	  uniplex	  assay	  was	  
configured	  such	  that	  each	  parasite	  was	  matched	  to	  its	  respective	  probe/primer	  mix.	  
A	  negative	  control	  consisted	  of	  deionized	  water	  and	  a	  positive	  control	  consisted	  of	  
an	  unrelated	  parasite.	  
	  
Validation	  of	  Parasite	  Probe/Primer	  in	  Multiplex	  Assays	  
	   The	  procedure	   for	  multiplex	  assays	  differed	   in	  that	  a	  mastermix	  was	  added	  
during	  the	  last	  step	  that	  contained	  multiple	  probes	  for	  different	  parasites,	  instead	  of	  






	   The	   parasitic	   infection	   rates	   for	   refugees	   in	   the	   study	   population	   as	  
determined	   by	   microscopy	   can	   be	   found	   in	   Figure	   4.	   	   Forty-­‐one	   percent	   were	  
infected	  with	  D.	  fragilis,	  31%	  were	  infected	  with	  G.	  lamblia	  and	  13%	  were	  infected	  
with	  S.	  stercoralis.	  Nine	  percent	  were	  co-­‐infected	  with	  D.	  fragilis	  and	  G.	  lamblia,	  and	  
6%	  were	  co-­‐infected	  with	  D.	  fragilis	  and	  S.	  stercoralis.	  Figure	  5	  represents	  the	  top	  2	  
countries	   of	   origin	   for	   the	   refugees	   included	   in	   the	   study	   population.	   Seventy-­‐six	  
percent	   of	   the	   refugees	   came	   from	   one	   of	   two	   countries,	   Burma	   or	   Cuba.	   	   The	  
remaining	   25%	   of	   refugees	   came	   from	   6	   other	   countries;	   Eritrea,	   Congo,	   Chad,	  
Nepal,	  Zimbabwe	  and	  one	  unknown	  country.	  The	  gender	  distribution	  of	  the	  sample	  
population	  was	  1.4	  male	   to	   female	  ratio	  as	  shown	   in	  Figure	  6.	  Figure	  7	  shows	   the	  
distribution	   of	   refugees	   broken	   down	   by	   age	   group.	   Forty-­‐seven	   percent	   were	  
between	  the	  ages	  of	  0	  and	  15,	  31%	  were	  between	  the	  ages	  of	  21-­‐40	  and	  22%	  were	  
agres	  56	  and	  above.	  Figure	  8	  represents	  the	  city	  of	  residence	  for	  the	  refugees	  in	  the	  
study	   population.	   Thirty	   one	   percent	   lived	   in	   Houston,	   22%	   lived	   in	   Dallas,	   16%	  
lived	  in	  Lewisville,	  and	  12%	  lived	  in	  Amarillo.	  The	  last	  19%	  lived	  in	  four	  other	  cities;	  




Uniplex	  PCR	  Results	  
	   The	  parasitic	  infections	  identified	  in	  the	  32	  refugees	  that	  made	  up	  the	  study	  
population	   by	   light	   microscopy	   included	   9	   infections	   with	   G.	   lamblia-­‐only,	   3	  
infections	   with	   G.	   lamblia	   and	   D.	   fragilis,	   12	   infections	   with	   D.	   fragilis-­‐only,	   4	  
infections	  with	  S.	  stercoralis-­‐only,	  and	  2	  infections	  with	  S.	  stercoralis	  and	  D.	  fragilis	  
(Table	  1).	  	  
The	   results	   for	   the	   uniplex	   assay	   of	  G.	   lamblia	   are	   shown	   in	   Figure	   9.	   The	  
probe	   for	   this	   parasite	   fluoresces	   at	   610	   nm.	   	   In	   Figures	   9	   to	   16,	   the	   color	   green	  
indicates	   a	   negative	   result	   (no	   detection	   of	   the	   parasite)	   and	   the	   color	   red	   is	   a	  
positive	  result	   (a	  detection	  of	   the	  parasite).	  The	   two	   flat	  green	   lines	  represent	   the	  
positive	   and	   negative	   controls.	   The	   negative	   control	   consisted	   of	  water	  while	   the	  
positive	   control	   contained	   the	   DNA	   of	   an	   unrelated	   parasite	   (a	   hookworm).	   Both	  
controls	  did	  not	  fluoresce.	  Twelve	  of	  12	  samples	  tested	  for	  G.	  lamblia	  were	  positive.	  
Based	  on	  these	  results,	  it	  was	  concluded	  that	  the	  uniplex	  assay	  to	  identify	  G.	  lamblia	  
was	  successful.	  
The	  results	   for	   the	  uniplex	  assay	  of	  D.	   fragilis	  are	  represented	   in	  Figure	  10.	  
The	  probe	  for	  this	  parasite	  fluoresces	  at	  440	  nm.	  Seventeen	  samples	  were	  tested	  for	  
D.	   fragilis,	   and	   as	   shown	   by	   the	   red	   curves	   in	   Figure	   10,	   14	   of	   17	   samples	   tested	  
positive.	  The	  five	  green	  curves	  represent	  three	  samples	  and	  two	  controls	  that	  tested	  
negative	   for	  D.	   fragilis.	   	   Even	   though	   100%	   of	   samples	   were	   not	   positive,	   it	   was	  
concluded	  that	  the	  uniplex	  assay	  to	  identify	  D.	  fragilis	  was	  successful.	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The	  results	  for	  the	  uniplex	  assay	  of	  S.	  stercoralis	  are	  shown	  in	  Figure	  11.	  This	  
probe	  fluoreseces	  at	  640	  nm.	  Six	  of	  6	  samples	  tested	  for	  S.	  stercoralis	  were	  negative.	  
Based	   on	   these	   results,	   it	   was	   concluded	   that	   the	   uniplex	   assay	   to	   identify	   S.	  
stercoralis	  was	  unsuccessful.	  	  
The	  percent	  agreement	  between	  the	  uniplex	  molecular	  assay	  and	  microscopy	  
is	  given	  in	  Table	  2.	  	  In	  the	  case	  of	  G.	  lamblia,	  there	  was	  a	  100%	  agreement	  between	  
microscopic	  and	  molecular	  methods.	   In	   the	  case	  of	  D.	   fragilis,	   there	  was	  an	  82.4%	  
agreement	  between	  the	  two	  methods.	  	  In	  the	  case	  of	  S.	  stercoralis,	  it	  was	  concluded	  
that	  the	  probe/primer	  mix	  did	  not	  work	  as	  intended.	  	  	  
	  
Multiplex	  PCR	  
The	  multiplex	  assays	  were	  configured	  such	  that	  each	  sample	  was	  tested	  with	  
a	   probe/primer	  mix	   for	  G.	   lamblia	   and	  D.	   fragilis,	   since	   the	  S.	   stercoralis	   probe	   or	  
primer	  was	  not	  working	  as	  intended.	  Theoretically,	  if	  a	  sample	  only	  had	  G.	  lamblia,	  
then	  it	  would	  only	  fluoresce	  at	  a	  wavelength	  of	  610	  nm,	  and	  if	  a	  sample	  only	  had	  D.	  
fragilis,	  it	  would	  fluoresce	  at	  a	  wavelength	  of	  440nm.	  If	  a	  sample	  had	  both	  parasites,	  
it	  would	  fluoresce	  at	  both	  wavelengths.	  	  	  
The	  results	   for	  the	  duplex	  assay	  of	  G.	   lamblia	  at	  a	  wavelength	  of	  610	  nm	  as	  
shown	  in	  Figure	  12.	  Just	  like	  the	  uniplex	  assay,	  12	  of	  12	  samples	  for	  G.	  lamblia	  tested	  
positive	  and	  2	  of	  2	  controls	  tested	  negative.	  It	  was	  important	  to	  verify	  that	  the	  9	  G.	  
lamblia-­only	   samples	   did	   not	   fluoresce	   at	   a	   wavelength	   of	   440	   nm.	   As	   shown	   in	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Figure	  13,	  9	  of	  9	  G.	  lamblia-­‐only	  samples	  were	  negative	  at	  a	  wavelength	  of	  440	  nm.	  
The	  two	  red	  curves	  represent	  2	  of	  3	  samples	  from	  individuals	  that	  were	  co-­‐infected	  
with	   both	   parasites.	   	   The	   third	   sample,	   from	   a	   refugee	   that	   was	   co-­‐infected	  with	  
both	  parasites,	  was	  not	  detected.	  	  
The	  results	  of	  the	  duplex	  assay	  to	  detect	  D.	  fragilis	  at	  a	  wavelength	  of	  440nm	  
are	  depicted	  in	  Figure	  14.	  	  Like	  the	  uniplex	  assay,	  the	  multiplex	  assay	  detected	  14	  of	  
17	  samples	   that	   contained	  D.	   fragilis,	   including	   two	  samples	   that	  were	  co-­‐infected	  
with	   G.	   lamblia	   and	   D.	   fragilis	   and	   two	   samples	   that	   were	   co-­‐infected	   with	   S.	  
stercoralis	  and	  D.	  fragilis.	  	  The	  five	  green	  curves	  represent	  the	  two	  negative	  controls	  
plus	  the	  three	  samples	  that	  tested	  negative	  for	  D.	  fragilis.	   	  It	  was	  important	  to	  then	  
verify	   that	   the	   12	   D.	   fragilis-­‐only	   samples	   and	   the	   2	   D.	   fragilis	   and	   S.	   stercoralis	  
samples	  did	  not	  fluoresce	  at	  a	  wavelength	  of	  610	  nm.	  Figure	  15	  shows	  that	  the	  12	  D.	  
fragilis-­‐only	  samples	  and	  the	  2	  D.	  fragilis	  and	  S.	  stercoralis	  samples	  were	  negative	  at	  
a	  wavelength	  of	  610	  nm.	  The	  three	  red	  curves	  represent	  3	  of	  3	  samples	  that	  were	  
co-­‐infected	  with	  D.	   fragilis	   and	  G.	   lamblia.	  These	   results	  agree	  with	   the	  previously	  
mentioned	  studies.	  
A	   summary	   of	   the	   agreement	   between	   multiplex	   PCR	   and	   microscopy	   is	  
displayed	  in	  Table	  3.	  	  Nine	  of	  nine	  samples	  that	  were	  positive	  microscopically	  for	  G.	  
lamblia,	  fluoresced	  at	  the	  expected	  wavelength	  of	  610	  nm	  and	  were	  not	  detected	  at	  
a	  wavelength	  of	  440	  nm.	  All	  3	  samples,	  in	  which	  both	  G.	  lamblia	  and	  D.	  fragilis	  were	  
present	   by	  microscopy,	  were	   detected	   at	   610	   nm	   and	   2	   of	   the	   samples	  were	   also	  
detected	   at	   a	   wavelength	   of	   440	   nm.	   	   Twelve	   of	   14	   samples	   microscopically	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confirmed	  to	  be	  positive	  for	  D.	  fragilis-­‐only	  or	  D.	  fragilis	  and	  S.	  stercoralis	  fluoresced	  
at	  440	  nm	  and	  did	  not	  fluoresce	  at	  610nm.	  Finally,	  the	  same	  results	  were	  obtained	  
when	  the	  3	  samples	  containing	  D.	  fragilis	  and	  G.	  lamblia	  were	  tested	  a	  second	  time.	  	  
	  
DISCUSSION	  	  
To	  summarize,	  the	  demographic	  analysis	  of	  the	  32	  refugees,	  the	  majority	  had	  
single	   parasitic	   infections	   with	   G.	   lamblia	   or	   D.	   fragilis.	   Three-­‐quarters	   of	   the	  
refugees	  came	  from	  one	  of	   two	  countries	  –	  Burma	  or	  Cuba	   .	   	  There	  was	  a	  1.4	   to	  1	  
male	  to	  female	  ratio.	  	  Forty-­‐seven	  percent	  of	  refugees	  were	  children	  in	  the	  0-­‐15	  age	  
group	  and	  31%	  were	  young	  adults	  between	  the	  ages	  of	  21-­‐40.	   	  Slightly	  more	  than	  
half	  of	  the	  refugees	  resided	  in	  Houston	  or	  Dallas.	  	  
This	   work	   resulted	   in	   the	   development	   of	   a	   successful	   multiplex	   assay	   to	  
identify	   two	   important	   intestinal	   parasites	   in	   Texas	   refugees	   –	   G.	   lamblia	   and	  D.	  
fragilis.	   	  For	  G.	  lamblia,	  there	  was	  100%	  agreement	  between	  uniplex	  and	  multiplex	  
assay	   results	   with	   microscopy	   results,	   and	   100%	   agreement	   between	   multiplex	  
assay	  results	  with	  microscopy	  results	  for	  co-­‐infection	  with	  D.	  fragilis.	  The	  molecular	  
assays	   developed	   had	   a	   0%	   false	   positive	   rate	   for	   detection	   of	   G.	   lamblia	   or	   co-­‐
infection	   of	  G.	   lamblia	  with	  D.	   fragilis.	   For	  D.	   fragilis,	   there	  was	   82.4%	   agreement	  
between	   uniplex	   and	  multiplex	   assay	   results	  with	  microscopy	   results,	   and	   a	   66%	  
agreement	  between	  multiplex	  assay	  results	  and	  microscopy	  results	  for	  co-­‐infection	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with	  D.	   fragilis	   and	  G.	   lamblia.	   These	   assays	   also	   had	   a	   0%	   false	   positive	   rate	   for	  
detection	  of	  D.	  fragilis	  or	  co-­‐infections	  of	  D.	  fragilis	  and	  G.	  lamblia.	  	  
The	   results	   of	   this	   investigation	  were	   consistent	  with	   the	   results	   found	   by	  
other	   investigators	   such	   as	   Tuniuchi	   and	   coworkers	   (2011),	   Bruijnesteijn	   and	  
coworkers	   (2009),	   and	   Verweij	   and	   coworkers	   (2004)	   (10,	   50,	   52).	   Uniplex	   and	  
multiplex	   RT-­‐PCR	   are	   extremely	   accurate	   at	   diagnosing	   parasitic	   infection	  with	   a	  
quick	   turn-­‐around	   time.	  Of	   the	  assays	   that	  were	  successfully	  validated,	   they	  had	  a	  
high	   sensitivity	   and	   specificity	   when	   compared	   to	   the	   golden	   standard	   of	   light	  
microscopy.	  
	   There	   were	   at	   least	   three	   limitations	   to	   this	   research.	   First,	   it	   was	   not	  
possible	  to	  verify	  the	  microscopic	  identification	  of	  parasites	  in	  the	  stool	  specimens.	  
Second,	   it	  was	  not	  possible	  to	  develop	  a	  successful	  assay	   for	  S.	  stercoralis	  due	  to	  a	  
malfunctioning	  probe	  or	  primer.	  Lastly,	  the	  sample	  size	  was	  small.	  	  
Possible	  future	  studies	  the	  author	  could	  carry	  out	  include	  repeating	  the	  study	  
with	   a	   larger	   sample	   size	   to	   further	   investigate	   the	   discrepancies	   between	  
microscopy	  and	  molecular	  testing	  techniques.	  In	  addition,	  the	  author	  would	  like	  to	  
configure	  other	  multiplex	  assays	  using	  additional	  sets	  of	  probe/primer	  to	  diagnose	  a	  
wider	   range	   of	   intestinal	   parasitic	   infections.	   Lastly,	   two	   intestinal	   parasites	   –	   E.	  
histolytica	   and	  E.	  dispar	   –	  are	   indistinguishable	  by	  microscopy.	   	  The	  author	  would	  




	   Based	  on	  these	  research	  results,	  the	  author	  would	  recommend	  that	  the	  DSHS	  
Molecular	  Biology	  Laboratory	  carry	  out	  continued	  research	  in	  developing	  multiplex	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Table	  1.	  Parasitic	  Infection	  in	  study	  population	  
Parasite	   Count	  
G.	  lamblia	   9	  
G.	  lamblia	  +	  D.	  fragilis	   3	  
D.	  fragilis	   12	  
S.	  stercoralis	   4	  









Table	  2.	  Agreement	  between	  uniplex	  PCR	  and	  microscopy	  





G.	  lamblia	   12	   12	   100%	  
D.	  fragilis	   14	   17	   82.4%	  











Table	  3.	  Agreement	  between	  multiplex	  PCR	  and	  microscopy	  
	   610	  nm	  (G.	  lamblia)	   440	  nm	  (D.	  fragilis)	  
G.	  lamblia	   9/9	  (100%)	   0/9	  (0%)	  
G.	  lamblia	  +	  D.	  fragilis	   3/3	  (100%)	   2/3	  (66.7%)	  
D.	  fragilis	  or	  	  
D.	  fragilis	  +	  S.	  stercoralis	  
0/14	  (0%)	   12/14	  (85.7%)	  


































Appendix	  A.	  Protocol	  for	  Real-­‐Time	  PCR	  
A. Vertrel	  Extraction	  from	  Stool	  Specimen	  
1. Label	   microfuge	   tubes	   with	   specimen	   ID	   that	   corresponds	   to	   stool	  
specimen.	  
2. Add	  0.5	  mL	  of	  nuclease-­‐free	  water	  into	  1.5	  mL	  microfuge	  tubes.	  
3. Add	  0.5	  mL	  Vertrel	  into	  microfuge	  tubes.	  
4. If	   solid	   stool,	   add	   approximately	   a	   pea	   size	   amount	   of	   stool	   with	   a	  
disposable	   transfer	   loop	   into	  appropriate	  microfuge	   tube.	   If	   liquid	  stool,	  
add	  approximately	  0.1	  mL	  of	  stool	  into	  appropriate	  microfuge	  tube.	  
5. Vortex	  each	  microfuge	  tube	  for	  1	  minute.	  
6. Centrifuge	  each	  microfuge	  tube	  for	  5	  minutes	  at	  2800	  RPM	  at	  4˚C.	  
B. MagNA	  Pure	  Extraction	  from	  Vertrel	  Specimen	  
1. Aliquot	  300	  µL	  of	  lysis	  buffer	  into	  a	  separate	  sample	  microfuge	  tube.	  
2. Add	  100	  µL	  of	  aqueous	  top	  Vertrel	  layer	  from	  extraction	  step	  into	  sample	  
microfuge	  tube.	  
3. Set	  up	  MagNA	  Pure	  protocols:	  
a. Sample	  volume	  is	  400	  µL	  
b. Elution	  volume	  is	  100	  µL	  
4. Load	   sample	   and	   reagents	   into	   MagNA	   Pure	   and	   run	  
‘Total_NA_Plasma_External_Lysis”	  protocol.	  
C. Real-­‐Time	  PCR	  Setup	  
1. In	  the	  PCR	  setup	  box:	  
a. Create	  and	  label	  tubes	  for	  each	  master	  mix	  (Appendix	  B).	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b. Mix	  by	   inversion	  and	   flicking	  the	   tube	  several	   times.	  Centrifuge	  
briefly	  to	  collect	  liquid	  at	  bottom	  of	  the	  tube.	  
2. Dispense	   21	   µL	   of	   each	   master	   mix	   to	   each	   appropriate	   well	   on	   a	  
LightCycler	  480	  (LC480)	  plate	  (1	  well	  per	  specimen	  per	  master	  mix).	  
3. Add	  4	  µL	  of	  MagNA	  Pure	  extractions	  to	  appropriate	  wells.	  
a. Be	  sure	  to	  include	  one	  positive	  and	  negative	  control	  for	  each	  of	  
the	  targets.	  
4. Seal	  LC480	  plate	  and	  centrifuge	  60	  seconds	  at	  3500	  rpm.	  	  
5. Load	  plate	  into	  LC480.	  
6. Start	  the	  real-­‐time	  PCR	  run:	  	  	  
a. Select	   'Run	   experiment	   from	   Template.'	   Select	   'Parasite	   Panel'	  
experiment	  file	  (Appendix	  C).	  The	  settings	  should	  be	  as	  follows.	  
The	  machine	   should	  have	  excitation/reading	   filters	   at	  498/580	  
nm,	   X,	   XXXXXXXXX	  with	   the	   following	   parameters:	  melt	   factor:	  
1.2;	   Quant	   factor:	   5;	   Max	   integration	   time:	   2	   (Parasite	   Panel	  
Detection	  Parameters).	  
b. Click	  'Run'.	  	  
D. Reading	  Results	  from	  the	  LightCycler	  480:	  
1. Click	   'Analysis'	   on	   left	   side	   of	   page,	   then	   'Fit	   Points'.	   Select	   the	   sample	  
subset.	  	  




3. Adjust	   left	  bar	  on	  Cycle	  Range	   tab	   to	  about	  5	  cycles	   left	   from	  estimated	  
crossing	  point	  of	  first	  amplification	  curve.	  
4. From	  the	  Noise	  Band	  tab	  adjust	  the	  horizontal	  bar	  above	  the	  background	  
















Appendix	  B.	  Mastermix	  Concentrations	  
	  
Parasite	   Amount	  of	  forward	  and	  
reverse	  primer	  from	  
100	  µM	  stock	  	  (µL)	  
Amount	  of	  probe	  





G.	  lamblia	   6.5	   2.5	   91	  
D.	  fragilis	   1.5	   2.5	   96	  


















Appendix	  C:	  Parasite	  Panel	  
1. Program	  the	  LighCycler:	  
a. Denature	  (1	  cycle)	  
i. 95˚C	  for	  10	  minutes;	  4.4˚C/s	  ramp	  rate	  
b. PCR	  (45	  cycles)	  
i. 95˚C	  for	  10	  sec;	  4.4˚C/s	  ramp	  rate	  
ii. 60˚C	  for	  1	  minute;	  2.2˚C/s	  ramp	  rate,	  single	  acquisition	  mode	  
c. Cooling	  (1	  cycle)	  












Appendix	  D.	  Probe/primers	  













1. 6FAM	  -­‐	  CAA	  TTC	  TAG	  CCG	  CTT	  AT	  -­‐	  MGBNFQ	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